A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab via Subcutaneous Administration in Healthy Volunteers
This research study is about a new medicine called Tozorakimab. We are testing two different forms of this medicine, which are both given as an injection under the skin. The main goal is to find out how well each form of the medicine is absorbed by the body and how it moves through your system. We are looking for healthy adults to take part. This type of study, called a Phase I study, is an early step in developing new medicines. It helps us understand the medicine better before it is given to patients who might need it for a specific illness. Your participation would help doctors learn more about this potential new treatment.
At a glance
What is this study about?
This study is a bit like a detective story for medicine. We have a new medicine called Tozorakimab, and it's designed to be given by an injection under the skin, similar to an insulin injection. The researchers want to understand how two slightly different versions, or 'dosage forms,' of this medicine behave once they are in your body. Think of it like comparing two different types of bottles for the same drink – does one bottle get the drink into your system quicker or more effectively than the other? That's what they're trying to figure out.
This is a very early stage of testing for the medicine, often called a Phase I study. This means it's not being tested on people who are unwell, but rather on healthy adult volunteers like you. The main aim is to check if the medicine is safe and how your body handles it. They will be measuring how much of the medicine gets into your bloodstream and how long it stays there after you receive each of the two different injections.
Why does this matter? Understanding how the medicine gets into the body is very important. It helps scientists decide the best way to give the medicine to future patients, making sure it works effectively and safely. Your help in this study can provide crucial information that could, much further down the line, benefit many people if this medicine proves successful for treating particular conditions.
Key takeaways
- This study is testing a new medicine called Tozorakimab.
- It's looking at how two different injection forms of the medicine are absorbed.
- Only healthy adults, aged 18 and over, can participate.
- It's an early-stage study to gather important safety and absorption information.
- Your involvement could help advance future medical treatments.
Who may be eligible?
To join this study, we are looking for healthy adult volunteers. This means you should generally be in good health and not have any ongoing medical conditions that might affect how the medicine works or how your body reacts to it.
Specifically, you need to be at least 18 years old. There is no upper age limit mentioned, so as long as you are over 18 and considered generally healthy by the study doctors, you could be eligible. Both men and women are welcome to take part in this study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you consider yourself to be generally healthy?
- Do you not have any major ongoing health conditions?
- Are you willing to have injections under your skin?
- Can you commit to regular clinic visits for blood tests and health checks?
What does participation involve?
If you decide to take part, you would receive injections of the study medicine under your skin. You would likely have several visits to the clinic, which might involve staying overnight, or coming in for several hours at a time. During these visits, doctors and nurses would take blood samples to measure how the medicine is moving through your body. They would also regularly check your health, for example, by measuring your heart rate and blood pressure.
You would receive both versions of the medicine, usually at different times, to allow for comparison. The total duration of your involvement could range from a few weeks to a couple of months, depending on the study's design, including follow-up appointments after your last dose to ensure you are well.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is Tozorakimab?
Tozorakimab is a new medicine that is being investigated. This study is an early step to understand how it works in the body.
Why do you need healthy volunteers?
Early studies like this are done with healthy volunteers to see how the medicine behaves in the body without other health conditions making it complicated to understand the results.
What does 'subcutaneous administration' mean?
It means the medicine is given as an injection just under the skin, rather than into a muscle or a vein.
Will I know if I'm getting the 'better' form of the medicine?
This study is designed to compare two forms of the medicine. The aim is to find out if one is better, not to give one group a 'better' treatment. Both forms are being tested.
Will I get paid for taking part?
Some studies offer payment for your time and expenses. You should ask the study team about this before you decide to join.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.